SELECT DISTINCT headline, body FROM newsdata WHERE id='8340.php' Hip Surgery: Information, Tips, Costs, Recovery, and More

ADVERTISEMENT

QualityHealth Tools

Support Groups

Connect with others who share similar health concerns.Get started now...

Health savings

Get more than $250 in savings from your favorite brands. Get started now...

Symptom Checker

Find out what your symptoms could mean. Get started now...

ADVERTISEMENT

     

Drug prevents bone loss in prostate cancer - Amgen

CHICAGO (Reuters) - Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss. The three-year study of more than 1,400 men with non-metastatic prostate cancer undergoing androgen deprivation therapy showed denosumab produced greater increases in bone mineral density at the lumbar spine and non-vertebral sites than a placebo. Men receiving denosumab also experienced less than half the incidence of new vertebral fractures than those receiving the placebo, Amgen said. Both findings were statistically significant, it said.

Copyright © 2008 MTS Corp, All rights reserved.

ADVERTISEMENT